Once-daily prostaglandin analog shows reduction of IOP for 24-hour period in glaucoma patients

Patients with open-angle glaucoma or hypertension showed a reduction in IOP when treated with a once-daily travoprost ophthalmic solution, according to a study.“The sustained 30% reduction in IOP seen with travoprost therapy may be a reasonable target for patients with open-angle glaucoma or hypertension,” Harvey DuBiner, MD, and colleagues reported in a poster presented at the World Glaucoma Congress. An IOP reduction threshold for glaucoma patients has yet to be determined.

Full Story →